Fitness to Practise Hearings

 

Jeffrey Paul Reaney

The Statutory Committee of the Pharmaceutical Society of NI will meet on 7 and 8 of September 2023 at 9:30 am to consider allegations of impairment in relation to the Registrant, Jeffrey Paul Reaney. Registration Number: 2317.

The particulars of the misconduct from which it is alleged that Jeffrey Paul Reaney’s impairment arises are as follows:

1. On various dates on and between 1 April 2017 and 31 July 2018, requesting, or allowing a request to be made, from Hillsborough Health Centre a Controlled Drug, namely Mezolar Matrix Transdermal Patches 25 micrograms/hour, knowing or believing that this medication was discontinued for a patient, namely Patient A.
2. On various dates on and between 1 April 2017 and 31 July 2018, requesting, or allowing a request to be made, from Hillsborough Health Centre a Controlled Drug, namely Mezolar Matrix Transdermal Patches 12 micrograms/hour, knowing or believing that this medication was discontinued for a patient, namely Patient A.
3. On various dates on and between 1 April 2017 and 31 December 2018, submitting, or causing, allowing or permitting to be submitted, claims for payment for dispensing of Mezolar to Patient A when no such medication was in fact dispensed.
4. On various dates on and between 1 April 2017 and 31 December 2018, having no proper or effective system in place to correctly identify items on a received prescription which should not be dispensed and to then code those items as having not been dispensed.
5. On various dates on and between 1 April 2017 and 31 December 2018, submitting, or causing, allowing or permitting to be submitted, claims for payment for dispensing Mezolar to Patient A when knowing or believing that no such medication was in fact dispensed and doing so dishonestly intending to make a gain or cause loss to another (namely BSO).
6. Knowing that Mezolar was a discontinued medication for Patient A, failing to put in place or have any sufficient mechanism or procedure to ensure that Mezolar, a Controlled Drug, was not ordered repeatedly from Patient A’s GP.
7. Failing to ensure the safe and effective operation of a pharmacy by failing to properly supervise and manage (a) the requesting and ordering of repeat prescription items, and (b) the action to be taken, or the standard procedure to be followed, when a prescription contained an unnecessary item, particularly a Controlled Drug.

For the purposes of paragraph 1(3) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 as amended and Regulation 26(11) of the Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012 and the following principles and obligations contained in the Code of Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016) are regarded by the Pharmaceutical Society of Northern Ireland as relevant to the proceedings.  Further, the Pharmaceutical Society of Northern Ireland alleges that the registrant is in breach of these principles and associated obligations by reason of the misconduct particularised above.

The general principle of registration as a pharmacist that requires you to act to promote and maintain public confidence in the pharmacy profession.

• Principle 1 – Always put the patient first and, in particular, standard 1.1 and 1.2 and the associated obligations set out below.
  • Standard 1.1 –Treat those in your care with respect and dignity.
  • Standard 1.1.1 – Always consider, and act in, the best interests of the patient or service user.
• Principle 2 – Provide a safe and quality service and, in particular, standard 2.1 and 2.3 and the associated obligations set out below.
  • Standard 2.1 – Provide safe, effective and quality care.
  • Standard 2.1.2 – Effectively control and manage the sale or supply of medicinal and related products paying particular attention to those with a potential for abuse or dependency.
  • Standard 2.1.4 – Ensure that workload or working conditions do not compromise patient care or public safety.
  • Standard 2.1.5 – Make sure that your actions do not prevent or inhibit others from complying with their legal or professional obligations.
  • Standard 2.1.6 – Ensure that you do not, whether by actions or omissions, create a risk to patient care or public safety.
  • Standard 2.1.12 – Ensure you are aware of and adhere to all relevant legislation, and all current standards and guidance which apply to your practise.
  • Standard 2.3 – Record, store and process data clearly and accurately and, in particular standard 2.3.1.
  • Standard 2.3.1 – Complete records promptly or as soon as reasonable practicable after the patient intervention or activity has occurred.
  • Standard 2.3.3 – Ensure all entries in any record are accurate, clearly and legibly written and attributable.
  • Standard 2.3.4 – Keep all records securely and in an organized manner and for the appropriate period of time.
• Principle 3 – Act with professionalism and integrity at all times and, in particular, standard 3.1 and the associated obligations set out below.
  • Standard 3.1 – Act with honesty and integrity at all times.
  • Standard 3.1.1 – Adhere to accepted and acceptable standards of personal and professional conduct at all times both inside and outside the work environment.
  • Standard 3.1.7 – Make sure that any documents you complete or sign are not false or misleading, or contain false or misleading information. Take all steps that are reasonable necessary to ensure that recorded information is correct and complete. Do not omit relevant information.

By his acts or omissions, it is alleged that the Registrant has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene remotely via an online platform.   If a member of the public has an inquiry about this hearing, they should contact the Acting Secretary to the Statutory Committee: june.alexander@psni.org.uk

 

Dr John Kurtis Moffatt

The Statutory Committee of the Pharmaceutical Society of NI will meet on 20^th and 21^st April 2023 to consider allegations of impairment in relation to the Registrant, Dr Kurtis Moffatt. Registration Number: 5843

The particulars of the misconduct and the relevant criminal convictions from which it is alleged that Dr Moffatt’s impairment arises are as follows:

Misconduct:

1. On 11th June 2021, whilst employed as a locum pharmacist for Bestway Belfast Chemists Ltd t/a Well Pharmacy, at 26 The Diamond, Rathcoole, Newtownabbey, and whilst undertaking the role of Responsible Pharmacist within that pharmacy, the Registrant abused his position as the Responsible Pharmacist and unlawfully obtained a controlled drug listed in Schedule 4 of Part 1 of the Misuse of Drugs Regulations (Northern Ireland) 2002 and in Schedule 2 to the Misuse of Drugs Act 1971, namely two boxes of Diazepam 5mg (28 tablets).

Criminal Convictions:

• On 31st May 2022, at Laganside Courthouse, the Registrant pleaded guilty to and was convicted of three separate offences particularised below: –
  • • (i) On the 8th day of June 2021, he stole toiletries to the value of £30.35 belonging to David McLornan and Well Pharmacy contrary to Section 1 of the Theft Act (Northern Ireland) 1969;
    • (ii) On the 11th day of June 2021, he stole Diazepam tablets belonging to David McLornan and Well Pharmacy contrary to Section 1 of the Theft Act (Northern Ireland) 1969; and
    • (iii) On the 11th day of June 2021, he unlawfully had in your possession a controlled drug of Class C of Schedule 2 to the Misuse of Drugs Act 1971, namely Diazepam in contravention of section 5(1) of the Misuse of Drugs Act 1971, contrary to Section 5(2) of the Misuse of Drugs Act 1971.

3. On 7th July 2022, he was sentenced to a Community Service Order requiring you to perform 150 hours of unpaid work. For the purposes of paragraph 1(3) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 as amended and Regulation 26(11) of the Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012 and the following principles and obligations contained in the Code of Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016) are regarded by the Pharmaceutical Society of Northern Ireland as relevant to the proceedings. Further, the Pharmaceutical Society of Northern Ireland alleges that he is in breach of these principles and associated obligations by reason of the misconduct and criminal convictions particularised above.

• The general principle of registration as a pharmacist that requires you to act to promote and maintain public confidence in the pharmacy profession
  • Principle 2 – Provide a safe and quality service and, in particular, standard 2.1 and 2.3 and the associated obligations set out below.
    • Standard 2.1 – Provide safe, effective and quality care.
    • Standard 2.1.1 – Promote and ensure the safe, effective and rational use of medicines, medicinal products and therapies.
    • Standard 2.1.2 – Effectively control and manage the sale or supply of medicinal and related products paying particular attention to those with a potential for abuse or dependency.
    • Standard 2.1.6 – Ensure that you do not, whether by actions or omissions, create a risk to patient care or public safety.
    • Standard 2.1.11 – Avoid treating yourself or anyone with whom you have a close personal relationship except for minor ailments or in an emergency.
    • Standard 2.1.12 – Ensure you are aware of and adhere to all relevant legislation, and all current standards and guidance which apply to your practise
• Principle 3 – Act with professionalism and integrity at all times and, in particular, standard 3.1 and the associated obligations set out below.
  • • Standard 3.1 – Act with honesty and integrity at all times.
    • Standard 3.1.1 – Adhere to accepted and acceptable standards of personal and professional conduct at all times both inside and outside the work environment.
    • Standard 3.1.2 – Maintain public trust and confidence in your profession by acting with honesty and integrity in your dealings with others. This applies to your professional, business and educational activities.

By his acts or omissions, it is alleged that he has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene at 73 University Street, Belfast. The hearing is subject to Covid-19 guidelines and access to the public may be limited. If a member of the public has an inquiry about this hearing, they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk.

 

Steven Lowery

The Statutory Committee of the Pharmaceutical Society of NI will meet on 8^th December 2022 to consider allegations of impairment in relation to the Registrant, Mr. Steven Lowery Registration Number: 3340

It is alleged that Mr. Lowery’s fitness to practise as a registered pharmacist may be impaired, pursuant to Paragraph 4(1)(a) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 by reason of misconduct.

The particulars of the alleged misconduct from which it is alleged that impairment of fitness to practise arises are set out as follows, namely:

That Mr Lowery, as a director of Dunmore Pharma Ltd, and holding the role of superintendent pharmacist for that company, and having effective control over the business:

1. On various dates on and between 22nd April 2020 and 19th July 2021 the Registrant, as superintendent of Dunmore Pharma Ltd, caused or allowed controlled drugs in schedule 1 and 2 of the Misuse of Drugs Regulations (Northern Ireland ) 2002 to be received into a Pharmacy, namely Dunmore Pharmacy, without making, or causing to be made, an appropriate entry in a Controlled Drug Register in contravention of Regulations 19 and 20 of the Misuse of Drugs Regulations (Northern Ireland ) 2002.
2. On various dates on and between 11th February 2021 and 19th July 2021 the Registrant, as superintendent of Dunmore Pharma Ltd, caused or allowed controlled drugs in schedule 1 and 2 of the Misuse of Drugs Regulations (Northern Ireland ) 2002 to be supplied from a Pharmacy, namely Dunmore Pharmacy, without making, or causing to be made, an appropriate entry in a Controlled Drug Register in contravention of Regulations 19 and 20 of the Misuse of Drugs Regulations (Northern Ireland ) 2002.
3. On various dates on and between 22nd April 2020 and 19th July 2021 the Registrant, as superintendent of Dunmore Pharma Ltd, caused or allowed controlled drugs in schedule 1 and 2 of the Misuse of Drugs Regulations (Northern Ireland ) 2002 to be received into and supplied from a Pharmacy, namely Dunmore Pharmacy, without making, or causing to be made, an appropriate record in breach of the Pharmacy’s Standard Operating Procedure.

For the purposes of paragraph 1(3) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 as amended and Regulation 26(11) of the Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012 and the following principles and obligations contained in the Code of Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016) are regarded by the Pharmaceutical Society of Northern Ireland as relevant to the proceedings.  Further, the Pharmaceutical Society of Northern Ireland alleges that the Registrant is in breach of these principles and associated obligations by reason of the misconduct particularised above.

• The general principle of registration as a pharmacist that requires you to act to promote and maintain public confidence in the pharmacy profession
• Principle 1 – Always put the patient first and, in particular, standard 1.1 and 1.2 and the associated obligations set out below.
  • Standard 1.1 –Treat those in your care with respect and dignity.
    • Standard 1.1.1 – Always consider, and act in, the best interests of the patient or service user

• Principle 2 – Provide a safe and quality service and, in particular, standard 2.1 and 2.3 and the associated obligations set out below.
  • Standard 2.1 – Provide safe, effective and quality care.
    • Standard 2.1.1 – Promote and ensure the safe, effective and rational use of medicines, medicinal products and therapies.
    • Standard 2.1.2 – Effectively control and manage the sale or supply of medicinal and related products paying particular attention to those with a potential for abuse or dependency.
    • Standard 2.1.4 – Ensure that workload or working conditions do not compromise patient care or public safety
    • Standard 2.1.5 Make sure that your actions do not prevent or inhibit others from complying with their legal or professional obligations
    • Standard 2.1.6 – Ensure that you do not, whether by actions or omissions, create a risk to patient care or public safety.
    • Standard 2.1.12 – Ensure you are aware of and adhere to all relevant legislation, and all current standards and guidance which apply to your practise
  • Standard 2.3 – Record, store and process data clearly and accurately and, in particular standard 2.3.1
    • Standard 2.3.1 – Complete records promptly or as soon as reasonable practicable after the patient intervention or activity has occurred.
    • Standard 2.3.3 – Ensure all entries in any record are accurate, clearly and legibly written and attributable.
    • Standard 2.3.4 – Keep all records securely and in an organized manner and for the appropriate period of time
• Principle 3 – Act with professionalism and integrity at all times and, in particular, standard 3.1 and the associated obligations set out below.
  • Standard 3.1 – Act with honesty and integrity at all times.
    • Standard 3.1.1 – Adhere to accepted and acceptable standards of personal and professional conduct at all times both inside and outside the work environment.
    • Standard 3.1.7 – Make sure that any documents you complete or sign are not false or misleading, or contain false or misleading information. Take all steps that are reasonable necessary to ensure that recorded information is correct and complete. Do not omit relevant information

By his acts or omissions, it is alleged that the Registrant has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene at 73 University Street, Belfast. The hearing is subject to Covid-19 guidelines and access to the public may be limited. If a member of the public has an inquiry about this hearing, they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk

 

Richard Lyness

In accordance with Regulation 39(1) of The Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012, this hearing was adjourned by the Chair of the Statutory Committee on 13th October 2022. A rescheduled date will be published in due course. 

The Statutory Committee of the Pharmaceutical Society of NI will meet on 13th and14th October 2022 to consider allegations of impairment in relation to the Registrant, Mr. Richard Lyness, Registration Number 4306

It is alleged that Mr. Lyness’s fitness to practise as a registered pharmacist may be impaired, pursuant to Paragraph 4(1)(a) and (d) of Schedule 3 of the Pharmacy (Northern Ireland) Order 1976 by reason of misconduct and criminal convictions.

The particulars of the alleged misconduct and criminal convictions from which it is alleged that impairment of fitness to practise arises are set out as follows, namely:

Misconduct:

1. That on 15 and 16 September 2018, whilst on duty as the Responsible Pharmacist at Cohens Chemist, Yarm Medical Centre, the Registrant slept in the dispensary.
2. That on 15 September 2018, whilst on duty as the Responsible Pharmacist at Cohens Chemist, Yarm Medical Centre, the Registrant did not complete the RP log in a timely fashion and as required.
3. That on 16 September 2018, whilst on duty as the Responsible Pharmacist at Cohens Chemist, Medical Centre, when Patient A attended the pharmacy to collect Buprenorphine medication the Registrant:

• allowed a dispensary assistant, referred to as Colleague 1, to access and dispense the medication to Patient A unsupervised;
• did not conduct a clinical or accuracy check on the prescription in accordance with the Standard Operating Procedures (SOP);
• did not complete the back of the prescription in accordance with the SOP which led to Patient A going without medication for two days; and
• returned to sleep in the dispensary which led Colleague 1 to handout and supervise Patient’s A consumption of the medication in the shop area.

4. Allegation 4 has been redacted
5. Allegation 5 has been redacted
6. The Registrant failed, either promptly or at all, to inform the Pharmaceutical Society of Northern Ireland of circumstances, known to him, that may have called into question his fitness to practise or had the potential to bring the profession into disrepute.

Criminal Conviction:

7. The particulars of the criminal convictions are set out below:
   1. 1. On 12 March 2021 the Registrant pleaded guilty to and were convicted of an offence namely that on and between 1 September 2020 and 6 October 2020, he pursued a course of conduct which amounted to harassment which he knew or ought to have known amounted to harassment contrary to to Article 4(1) of the Protection from Harassment (NI) Order 1997.

1. 1. 2. On 12 March 2021 the Registrant pleaded guilty to and were convicted of an offence namely that on and between 28 August 2020 and 8 September 2020, he for the purpose of causing annoyance, inconvenience or needless anxiety too another persistently made use of a public electronic communications network contrary to to Section 127(2)(c) of the Communications Act 2003.

1. 1. 3. On 15 January 2021 the Registrant pleaded guilty to and was convicted of an offence namely that on and between 10 October 2020 and 29 October 2020, he pursued a course of conduct which amounted to harassment which he knew or ought to have known amounted to harassment contrary to to Article 4(1) of the Protection from Harassment (NI) Order 1997.

1. 1. 4. On 12 March 2021 the Registrant pleaded guilty to and was convicted of an offence namely that on and between 31 October 2020 and 3 November 2020, he pursued a course of conduct which amounted to harassment which he knew or ought to have known amounted to harassment contrary to to Article 4(1) of the Protection from Harassment (NI) Order 1997.

1. 1. 5. On 12 March 2021 the Registrant pleaded guilty to and was convicted of an offence namely that on and between 27 November 2020, he for the purpose of causing annoyance, inconvenience or needless anxiety too another persistently made use of a public electronic communications network contrary to to Section 127(2)(c) of the Communications Act 2003.

1. 1. 6. On 12 March 2021 the Registrant pleaded guilty to and was convicted of an offence namely that on and between 22 December 2020, he contravened a non-molestation order contrary to to Article 25(a) of the Family Homes and Domestic Violence (NI) Order 1998.

1. 1. 7. On 18 June 2021 the Registrant pleaded guilty to and was convicted of an offence namely that on and between 10 March 2021 and 24 April 2021, he pursued a course of conduct which amounted to harassment which he knew or ought to have known amounted to harassment contrary to to Article 4(1) of the Protection from Harassment (NI) Order 1997.

 

8. For the purposes of paragraph 1(3) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 as amended and Regulation 26(11) of the Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012, the following principles and obligations (contained in the Pharmaceutical Society of Northern Ireland’s Code of Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016)) are regarded by the Pharmaceutical Society of Northern Ireland as relevant to the proceedings. Further, the Pharmaceutical Society of Northern Ireland alleges that the Registrant is in breach of these principles and associated obligations by reason of the misconduct and criminal convictions above.

• The general principle of registration as a pharmacist that requires you to act to promote and maintain public confidence in the pharmacy profession.
• Principle 2 – Provide a Safe and Quality Service and in particular, standard 2.1.
  • Standard 2.1 – Provide safe, effective and quality care
  • Standard 2.1.2 – Effectively control and manage the sale or supply of medicinal and related products paying particular attention to those with a potential for abuse or dependency.
  • Standard 2.1.6 – Ensure that you do not, whether by your actions or omissions, create a risk to patient care or public safety.
• Principle 3 – Act with professionalism and integrity at all times and in particular, Standard 3.1 and 3.3.
  • Standard 3.1 – Act with honesty and integrity at all times.
  • Standard 3.1.1 – Adhere to accepted and acceptable standards of personal and professional conduct at all times both inside and outside the work environment.
  • Standard 3.1.2 – Maintain public trust and confidence in your profession by acting with honesty and integrity in your dealings with others. This applies to your professional, business and educational activities.
  • Standard 3.1.4 – Honour commitments, agreements and arrangements for the provision of professional services.
  • Standard 3.1.6 – promptly inform the regulator, your employer and other relevant authorities of any circumstances that may call into question your fitness to practise or has the potential to bring the profession into disrepute.
  • Standard 3.3 – Use social networking and electronic communication appropriately.
  • Standard 3.3.1 – Ensure appropriate and responsible use of social networking sites and other forms of electronic communication.

9. By the Registrants acts or omissions, it is alleged that he has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene at 73 University Street, Belfast. The hearing is subject to Covid-19 guidelines and access to the public may be limited. If a member of the public has an inquiry about this hearing, they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk

 

Heather Trueick

This hearing is part-heard and will reconvene on Tuesday 20th December 2022 and Monday 9th January 2023.

In accordance with Regulation 39(1) of The Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012, this hearing was postponed by the Chair of the Statutory Committee on 4th October 2022. The hearing has been relisted for 1st and 2nd December 2022.

The Statutory Committee of the Pharmaceutical Society of NI will meet on 6^th and 7^th October 2022 to consider allegations of impairment in relation to the Registrant, Ms. Heather Trueick, Registration Number 2448 R.

It is alleged that Ms. Heather Trueick’s fitness to practise as a registered pharmacist may be impaired, pursuant to Paragraph 4(1)(a) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 by reason of misconduct.

The particulars of the alleged misconduct from which it is alleged that impairment of fitness to practise arises are set out as follows, namely:

Misconduct:

1. On various dates on and between 18 November 2019 and 1st February 2020 the Registrant, as superintendent of Wynrose Limited, failed to ensure that records of private prescriptions were completed and retained properly and in a manner that complied with Regulation 253 of the Human Medicines Regulations.
2. On various dates on and between 18 November 2019 and 1st February 2020 the Registrant failed to ensure that she properly completed records of private prescriptions in a manner that complied with Regulation 253 of the Human Medicines Regulations.
3. On various dates on and between 18 November 2019 and 1st February 2020 the Registrant, as superintendent of Wynrose Limited, failed to ensure that the pharmacy’s standard operating procedure was followed with respect to the recording of private prescriptions.
4. On various dates on and between 18 November 2019 and 1st February 2020 the Registrant failed to follow the pharmacy’s standard operating procedure with respect to the recording of private prescriptions.
5. On 23rd January 2020, as superintendent of Wynrose Limited, the Registrant caused, allowed, or permitted medicinal products other than medicinal products on a general sale list, ordered via an online platform, to be prepared and dispensed from McFaddens Pharmacy other than under the supervision and control of a pharmacist.
6. On 23rd January 2020, as superintendent of Wynrose Limited, the Registrant caused, allowed, or permitted medicinal products, other than medicinal products on a general sale list, ordered via an online platform, to be prepared and dispensed from McFaddens Pharmacy without the knowledge of the Responsible Pharmacist.
7. On 23rd January 2020 as superintendent of Wynrose Limited, the Registrant failed to manage and secure the safe and effective running of the pharmacy business with respect to the supply of medicinal products, other than medicinal products on a general sale list, ordered via an online platform.
8. Other than at 7 above, on various dates on and between 18 November 2019 and 30 November 2020 as superintendent of Wynrose Limited, the Registrant failed to manage and secure the safe and effective running of the pharmacy business with respect to the supply of medicinal products, other than medicinal products on a general sale list, ordered via an online platform.
9. On various dates on and between 18 November 2019 and 30 November 2020 as superintendent of Wynrose Limited, the Registrant failed to put in place suitable arrangements to allow the safe and effective dispensing of medicinal products, other than medicinal products on a general sale list, ordered via an online platform.
10. On various dates on and between 18 November 2019 and 30 November 2020, as superintendent of Wynrose Limited, the Registrant caused, allowed or permitted various pharmacists engaged by the business to dispense medicinal products, other than medicinal products on a general sale list, ordered via an online platform:

• • without their normal prescriber, or general practitioner, being notified about the supply, and
  • where the medicinal product dispensed had a potential for abuse or dependency.

For the purposes of paragraph 1(3) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 as amended and Regulation 26(11) of the Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012, the following principles and obligations contained in the Code of Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016) and the Standards and Guidance for Internet Pharmacy Services in Northern Ireland are regarded by the Pharmaceutical Society of Northern Ireland as relevant to the proceedings.  Further, the Pharmaceutical Society of Northern Ireland alleges that the Registrant is in breach of these principles and associated obligations by reason of the misconduct particularised above.

2016 Code:

• The general principle of registration as a pharmacist that requires to act to promote and maintain public confidence in the pharmacy profession
• Principle 1 – Always put the patient first and, in particular, standard 1.1 and 1.2 and the associated obligations set out below.
  • Standard 1.1 –Treat those in your care with respect and dignity.
    • Standard 1.1.1 – Always consider, and act in, the best interests of the patient or service user
    • Standard 1.2 – Uphold the duty of candor and raise concerns appropriately
    • Standard 1.2.1 – Contribute to and foster a culture of openness, honesty and learning
• Principle 2 – Provide a safe and quality service and, in particular, standard 2.1 and 2.3 and the associated obligations set out below.
  • Standard 2.1 – Provide safe, effective and quality care.
    • Standard 2.1.1 – Promote and ensure the safe, effective and rational use of medicines, medicinal products and therapies.
    • Standard 2.1.2 – Effectively control and manage the sale or supply of medicinal and related products paying particular attention to those with a potential for abuse or dependency.
    • Standard 2.1.6 – Ensure that you do not, whether by actions or omissions, create a risk to patient care or public safety.
    • Standard 2.1.12 – Ensure you are aware of and adhere to all relevant legislation, and all current standards and guidance which apply to your practise
    • Standard 2.3- Record, store and process data clearly and accurately.
    • Standard 2.3.3 – Ensure all entries in any record are accurate, clearly and legibly written and attributable.
    • Standard 2.3.4 – Keep all records securely and in an organized manner and for the appropriate period of time
• Principle 3 – Act with professionalism and integrity at all times and, in particular, standard 3.1 and the associated obligations set out below.
  • Standard 3.1 – Act with honesty and integrity at all times.
    • Standard 3.1.1 – Adhere to accepted and acceptable standards of personal and professional conduct at all times both inside and outside the work environment.
    • Standard 3.1.2 – Maintain public trust and confidence in your profession by acting with honesty and integrity in your dealings with others. This applies to your professional, business and educational activities.
    • Standard 3.1.7 – Make sure that any documents you complete or sign are not false or misleading, or contain false or misleading information. Take all steps that are reasonable necessary to ensure that recorded information is correct and complete. Do not omit relevant information

Standards and Guidance for Internet Pharmacy Services in Northern Ireland

• Standard 5.1 (5.1.1 to 5.1.7)
• Standard 5.2 (5.2.1 to 5.2.9)

And in particular –

• 2.3 – Ensure a pharmacist assesses the clinical appropriateness of the prescription for the patient
• 2.4 – Ensure that the patient, or his/her carer, receives sufficient information to enable the safe and effective use of the medicine and is aware how further information can be obtained
• 2.5 – Advise the patient to go to a local pharmacy whenever a prescription indicates that his interests would be better served by a face-to-face consultation with a pharmacist or another appropriate healthcare professional
• Standard 9 (9.1 to 9.5)

And in particular –

• 4 – A pharmacist providing internet pharmacy services must maintain records of the information upon which decisions to supply were made
• 5 – A pharmacist providing internet pharmacy services must maintain records of the identity of the pharmacist who has assumed professional responsibility for supply of a medicine following an email/online request to purchase

By the Registrant’s acts or omissions, it is alleged that she has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene at 73 University Street, Belfast. The hearing is subject to Covid-19 guidelines and access to the public may be limited. If a member of the public has an inquiry about this hearing, they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk

 

Carole Anne Fullarton-Healey

The Statutory Committee of the Pharmaceutical Society of NI will meet on 30^th and 31^st August 2022 to consider allegations of impairment in relation to the Registrant, Ms Carole Anne Fullarton-Healey, Registration Number 3627.

Summary of allegations:

It is alleged that Ms Fullarton-Healey’s fitness to practise as a registered pharmacist may be impaired, pursuant to Paragraph 4(1)(a) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 by reason of misconduct.

The particulars of the alleged misconduct from which it is alleged that impairment of fitness to practise arises are set out as follows, namely:

Misconduct:

1. On and between 1 November 2019 and 8 March 2021, as Superintendent, the Registrant failed to ensure that Fullarton Pharmacy Limited was organized or operated in such a way that the extemporaneous manufacture and preparation of unlicensed medicines complied with the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
2. On and between 1 November 2019 and 26 November 2019, as Superintendent, the Registrant caused, allowed or permitted an unlicensed medicine (namely teething powders) to be manufactured and offered for sale at Fullarton Pharmacy without any manufacturing records being kept contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
3. On or about 21 November 2019, as Superintendent, the Registrant caused, allowed or permitted another pharmacist to extemporaneously prepare unlicensed medicine (namely teething powders) in Fullarton Pharmacy without associated manufacturing records contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
4. Until the introduction of a standard operating procedure for the extemporaneous preparation of medicines in December 2019 the Registrant, as Superintendent, failed to ensure that Fullarton Pharmacy Limited had a relevant standard operating procedure with respect to this activity.
5. On various dates on and between 1 November 2019 and 15 June 2020, as Superintendent an, on occasions during this period, Responsible Pharmacist, the Registrant caused, allowed or permitted extemporaneously prepared unlicensed medicines (namely teething powders and colic mixture) to be labelled and offered for sale in Fullarton Pharmacy or McDowell’s Pharmacy with incorrect or imprecise expiry dates contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
6. On or about 16 November 2019, as Superintendent, the Registrant caused, allowed or permitted another pharmacist to extemporaneously prepare unlicensed medicine (namely teething powders) in McDowell’s Pharmacy with an incorrect expiry date on the manufacturing records and label contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
7. On or about 11 December 2019, as Superintendent, the Registrant caused, allowed or permitted another pharmacist to extemporaneously prepare unlicensed medicine (namely teething powders) in McDowell’s Pharmacy with inadequate manufacturing records (lacking manufacturer details, batch numbers expiry dates and a note of who prepared the teething powders) contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
8. On or about 22 January 2020, as Superintendent, the Registrant caused, allowed or permitted another pharmacist to label and offer for sale in McDowell’s Pharmacy an extemporaneously prepared unlicensed medicine (namely teething powders) with an incorrect manufacturing date contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
9. On or about 7 February 2020, as Superintendent and Responsible Pharmacist, the Registrant caused, allowed or permitted extemporaneously prepared unlicensed medicine (namely teething powders) to be labelled and offered for sale with an incorrect manufacturing date contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
10. On or about 10 February 2020, as Superintendent, the Registrant caused, allowed or permitted another pharmacist to extemporaneously prepare unlicensed medicine (namely colic mixture) in McDowell’s Pharmacy with inadequate manufacturing records (lacking manufacturer details, batch numbers and expiry dates) contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).
11. On various dates on and between 1 November 2019 and 15 June 2020, as superintendent, the Registrant caused, allowed or permitted extemporaneously prepared unlicensed medicines (namely teething powders and colic mixture) to be offered for sale with approximate and imprecise expiry dates contrary to the Pharmaceutical Society of Northern Ireland’s Professional Standards and Guidance for the Sale and Supply of Medicines (section 4).

For the purposes of paragraph 1(3) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 as amended and Regulation 26(11) of the Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012, the following principles and obligations (contained in the Pharmaceutical Society of Northern Ireland’s Code of Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016)) are regarded by the Pharmaceutical Society of Northern Ireland as relevant to the proceedings.  Further, the Pharmaceutical Society of Northern Ireland alleges that the Registrant is in breach of these principles and associated obligations by reason of the misconduct particularised above.

 

• The general principle of registration as a pharmacist that requires you to act to promote and maintain public confidence in the pharmacy profession.
• Principle 2 – Provide a Safe and Quality Service and in particular, standards 2.1, 2.2 and 2.3
• Standard 2.1 – Provide safe, effective and quality care
  • Standard 2.1.1 – Promote and ensure the safe, effective and rational use of medicines, medicinal products and therapies.
  • Standard 2.1.6 – Ensure that you do not, whether by your actions or omissions, create a risk to patient care or public safety.
  • Standard 2.1.12 – Ensure you are aware of and adhere to all relevant legislation, and all current standards and guidance which apply to your practice.
• Standard 2.2 – Manage risk
  • Standard 2.2.2 – Apprise staff of medication safety issues, identify areas of high-risk practice and implement procedures and processes to minimise medication safety risks or associated issues arising.
  • Standard 2.2.3 – Where any risk, issue or problem is identified, arises, or occurs in your practice, take prompt action to prevent, minimise, follow up and resolve any such risk, issue or problem, and this includes risks, issues or problems relating to medicines and appliances.
• Standard 2.3 – Record, store and process data clearly and accurately
  • Standard 2.3.1 – Complete records promptly or as soon as reasonably practicable after the patient intervention or activity has occurred.
  • Standard 2.3.3 – Ensure all entries in any record are accurate, clearly and legibly written and attributable.
• Principle 3 – Act with professionalism and integrity at all times and in particular, standard 3.1
• Standard 3.1 – Act with honesty and integrity at all times.
  • Standard 3.1.1 – Adhere to accepted and acceptable standards of personal and professional conduct at all times both inside and outside the work environment
  • Standard 3.1.7 – Make sure that any documents you complete or sign are not false or misleading, or contain false or misleading information. Take all steps that are reasonably necessary to ensure that recorded information is correct and complete. Do not omit relevant information.
• Principle 4 – Communicate effectively and work properly with colleagues and in particular, standard 4.4
• Standard 4.4 – Supervise and delegate effectively.
  • Standard 4.4.5 – Take all reasonable steps to ensure that those persons you employ, or supervise, comply with all legal and professional requirements and best practice guidance.

By the Registrant’s acts or omissions, it is alleged that she has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene at 73 University Street, Belfast. The hearing is subject to Covid-19 guidelines and access to the public may be limited. If a member of the public has an inquiry about this hearing, they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk

 

John Patrick McGuigan

The Statutory Committee of the Pharmaceutical Society of NI will meet on 27 June 2022 to consider allegations of impairment in relation to the Registrant, Mr John Patrick McGuigan, Registration Number 4547.

Summary of allegations:

It is alleged that Mr McGuigan’s fitness to practise as a registered pharmacist may be impaired, pursuant to Paragraph 4(1)(a) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 by reason of misconduct.

The particulars of the alleged misconduct from which it is alleged that impairment of fitness to practise arises are set out as follows, namely:

1. On or about 14 June 2007, when applying to join the register of pharmaceutical chemists maintained by the Registrar of the Pharmaceutical Society of Northern Ireland, the Registrant made a false declaration by stating that he had not been convicted of an offence in a court of law whereas he was, in fact, on 22 February 2007 convicted of driving after consuming alcohol in excess of the prescribed limit contrary to Article 16(1)(a) of the Road Traffic (NI) Order 1995.
2. From 23 May 2008 until 12 May 2017, each year after his first registration with the Pharmaceutical Society of Northern Ireland, the Registrant made a false declaration on his yearly retention form in that he failed to declare that he was, on 22 February 2007, convicted of driving after consuming alcohol in excess of the prescribed limit contrary to Article 16(1)(a) of the Road Traffic (NI) Order 1995.
3. His actions, as described at paragraph 1 and 2 above, were dishonest in that (a) he knew that he was required to declare such a conviction, (b) he failed to declare the conviction at the point of first registration, and (c) he completed and submitted the retention form each year for 10 years, knowing that he had made a false declaration in the retention form.

The Society further alleges that the Registrant is in breach of selected principles and obligations of in the Pharmaceutical Society of Northern Ireland’s Code of Ethics (2009) and Code of Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016) by reason of misconduct.

By the Registrant’s acts or omissions, it is alleged that he has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene at 73 University Street, Belfast. The hearing is subject to Covid-19 guidelines and access to the public may be limited. If a member of the public has an inquiry about this hearing, they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk

 

Michael John McDaid

The Statutory Committee of the Pharmaceutical Society of NI will meet on 27 May 2022 to consider allegations of impairment in relation to the Registrant, Mr Michael John McDaid, Registration Number 3302.

Summary of allegations:

It is alleged that Mr. McDaid’s fitness to practise as a registered pharmacist may be impaired, pursuant to Paragraph 4(1)(g) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 by reason of a relevant police caution.

The particulars of the relevant police caution, from which it is alleged that impairment of fitness to practice arises, are as follows:

1. On 3 March 2021, the Registrant attended Musgrave Police Station and accepted a police caution in relation to the following offence – that between 2^nd and 24^th day of March 2020 the Registrant sold or supplied a Prescription Only Medicine (POM), namely Ranitidine, otherwise than in accordance with a prescription given by an appropriate practitioner, in contravention of Regulation 214(1) of the Human Medicines Regulations 2012, contrary to Regulation 255(1)(a) of the Human Medicines Regulations 2012.

For the purposes of paragraph 1(3) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 as amended and Regulation 26(11) of the Council of the Pharmaceutical Society of Northern Ireland (Fitness to Practise and Disqualification) Regulations (Northern Ireland) 2012, the following principles and obligations (contained in the Pharmaceutical Society of Northern Ireland’s Code of Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016)) are regarded by the Pharmaceutical Society of Northern Ireland as relevant to the proceedings.  Further, the Pharmaceutical Society of Northern Ireland alleges that the Registrant is in breach of these principles and associated standards by reason of the police caution particularised above.

• The general principle of registration as a pharmacist that requires a Registrant to act to promote and maintain public confidence in the pharmacy profession.
• Principle 2 – Provide a safe and quality service and, in particular, standard 2.1 and the associated obligations set out below.
• Standard 2.1 – Provide safe, effective and quality care.
• Standard 2.1.1 – Promote and ensure the safe, effective and rational use of medicines, medicinal products and therapies.
• Standard 2.1.2 – Effectively control and manage the sale or supply of medicinal and related products paying particular attention to those with a potential for abuse or dependency.
• Principle 3 – Act with professionalism and integrity at all times and, in particular, standard 3.1 and the associated obligations set out below.
• Standard 3.1 – Act with honesty and integrity at all times.
• Standard 3.1.1 – Adhere to accepted and acceptable standards of personal and professional conduct at all times both inside and outside the work environment.
• Standard 3.1.2 – Maintain public trust and confidence in your profession by acting with honesty and integrity in your dealings with others. This applies to your professional, business and educational activities.

By his acts or omissions, it is alleged that the Registrant has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene at 73 University Street, Belfast. The hearing is subject to Covid-19 guidelines and access to the public may be limited. If a member of the public has an inquiry about this hearing, they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk

 

Alexandra Bradley

The Statutory Committee of the Pharmaceutical Society of NI will meet on 05 and 06 May 2022 to consider allegations of impairment in relation to the Registrant, Ms. Alexandra Bradley, Registration Number 2835 IP.

Summary of allegations:

1. It is alleged that Ms. Bradley’s fitness to practise as a registered pharmacist may be impaired pursuant to Paragraph 4(1)(b) of Schedule 3 to the Pharmacy (Northern Ireland) Order 1976 by reason of deficient professional performance.

The particulars of the alleged deficient professional performance from which it is alleged that impairment of fitness to practise arises are set out as follows, namely:

(A) It is alleged that the Registrant’s ability to practise safely and effectively as a pharmacist is compromised by reason of the following matters –

(i) She displayed a lack of essential clinical knowledge;

(ii) She made errors with such frequency and to such an extent as to call into question her professional competence;

(iii) She failed to demonstrate the general skills and competencies required;

(iv) She failed to undertake tasks consistent with the role undertaken;

(v) She failed to adequately and contemporaneously record and code medical notes;

(vi) She failed to properly monitor and manage patients receiving anticoagulant medication;

(vii) She failed to properly undertake medication reviews and intervene when required;

(viii) She demonstrated a lack of insight into deficits identified;

(ix) She failed to respond adequately or at all to issues raised.

(B) Taken individually and collectively, the errors and competence issues identified above give rise to a concern about the Registrant’s ability to practise safely and effectively as a pharmacist.

(C) The Registrant’s performance consistently fell short of the required and expected standard.

(D)Potential and actual patient safety issues have been identified; and

(E)There is a specific concern with respect to the Registrant offering services as an independent prescriber (IP).

2. The Society further alleges that the Registrant is in breach of selected principles and obligations of the Pharmaceutical Society of Northern Ireland’s Code of Conduct Ethics and Performance (2016) by reason of deficient professional performance.
3. By the Registrant’s acts or omissions, it is alleged that she has (a) brought the profession into disrepute, (b) failed, on a professional basis, to observe the principles and obligations set out above and (c) undermined public confidence in the profession.

This hearing will convene at 73 University Street, Belfast. The hearing is subject to Covid-19 guidelines and access to the public may be limited. If a member of the public has an inquiry about this hearing, they should contact the Secretary to the Statutory Committee: peter.hutchinson@psni.org.uk

This hearing was adjourned on 06 May 2022. This hearing will reconvene on Thursday 23rd June 2022 09:30am.